In this groundbreaking study, we present an innovative artificial intelligence (AI)-driven diagnostic tool that leverages low-cost infrared spectroscopy to detect diabetes and lipid metabolism disorders at an early stage. The solution is designed to be accessible, portable, and scalable across low-resource settings, making it a potential game-changer in preventive healthcare, particularly in sub-Saharan Africa.
The AI model was trained using spectral data from blood samples, allowing it to recognize complex biochemical patterns associated with glucose and lipid abnormalities. Our approach achieved over 95% accuracy in validation tests, rivaling conventional lab diagnostics – but at a fraction of the cost and time.
This tool eliminates the need for complex and expensive laboratory infrastructure, offering a rapid, non-invasive screening method that can be used in community health settings and rural clinics. It aligns with global efforts to decentralize diagnostics and empower frontline health workers with AI-enabled tools.
